![]() |
市场调查报告书
商品编码
1986742
主动脉瓣置换市场报告:按手术类型、产品、最终用途和地区划分(2026-2034 年)Aortic Valve Replacement Market Report by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Sutureless Valve, and Others), End Use (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2026-2034 |
||||||
2025年全球主动脉瓣置换术市场规模达123亿美元。展望未来,IMARC集团预测,到2034年,该市场规模将达到271亿美元,2026年至2034年的复合年增长率为8.87%。主动脉疾病盛行率的上升、医疗保险系统的扩展以及微创手术(MIS)的日益普及是推动市场成长的关键因素。
主动脉瓣置换术是一种外科手术,用于替换心臟中病变或受损的主动脉瓣。通常采用传统的开胸手术,但也采用微创手术,例如透过较小的胸部切口或经腿部插入导管。此手术用于治疗影响瓣膜并控制心臟血流的疾病。它有助于恢復正常的血流,缓解症状,延长寿命并维持心肌功能。通常建议患有严重主动脉瓣疾病(包括主动脉瓣狭窄和主动脉瓣瓣膜闭锁不全)的患者进行手术,这些疾病通常伴随胸痛、呼吸困难和疲劳等症状。
主动脉疾病在一般人群中盛行率的快速增长以及易患此类疾病的老年人口的不断增加,是全球主动脉瓣置换术需求的主要驱动因素。此外,医疗保险体系的日益普及,为主动脉瓣置换术术提供经济支持并降低医疗成本,也促进了市场成长。同时,人们对主动脉疾病、其症状和诊断的认识不断提高,以及主动脉瓣置换术等治疗方法的便利性,也对市场产生了积极影响。此外,经导管主动脉瓣置换术(TAVR)的应用也日益广泛。这是一种微创手术(MIS),无需开胸即可置换主动脉瓣,通常是那些传统开胸手术风险较高的患者的首选。此外,微创手术具有术中併发症减少、住院时间缩短、疼痛减轻、术后护理负担减轻、恢復更快以及感染风险降低等优点,因此越来越受到青睐,这也推动了市场成长。此外,将人工智慧 (AI) 和机器学习 (ML) 应用于主动脉瓣置换术的成像技术,以识别併发症高风险患者并优化手术流程和术后护理,也促进了市场成长。同时,许多国家政府正采取措施,提供人人可及的高品质医疗服务。这些倡议,加上诊断技术的显着进步,共同推动了市场成长。
The global aortic valve replacement market size reached USD 12.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 27.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8.87% during 2026-2034. The increasing prevalence of aortic diseases, rising implementation of health insurance policies, and the growing adoption of MIS procedures represent some of the key factors driving the market.
Aortic valve replacement is a surgical procedure performed to replace a diseased or damaged aortic valve in the heart. It is usually operated through the traditional open-heart surgery, which involves incising the chest or using minimally invasive (MI) methods that require smaller incisions in the chest or a catheter incorporated in the leg. It treats diseases that affect the valves and controls blood flow through the heart. It aids in restoring normal blood flow, reducing symptoms, prolonging life, and preserving the function of the heart muscle. It is generally recommended for patients with severe aortic valve disease, including aortic stenosis or aortic regurgitation, that has symptoms like chest pain, shortness of breath, and fatigue.
The surging prevalence of aortic diseases among the masses and the increasing aging population that is more prone to developing these medical disorders represent one of the major factors driving the demand for aortic valve replacement around the world. Moreover, the rising implementation of health insurance policies that offer financial assistance for aortic valve replacement and reduce medical expenses is favoring the growth of the market. In addition, the growing awareness about aortic diseases, their symptoms, diagnosis, and the easy availability of the treatment options like aortic valve replacement is influencing the market positively. Apart from this, there is an increase in the adoption of transcatheter aortic valve replacement (TAVR), minimally invasive surgical (MIS) procedure that helps replace the aortic valve without open-heart surgery and is generally preferred by patients who are at major risk for traditional open-heart surgery. This, coupled with the rising preferences for MIS procedures on account of fewer operative complications, shorter hospitalization, less pain, reduced postoperative care, quicker recovery, and lower risk of infection, is propelling the growth of the market. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in imaging techniques of aortic valve replacement to identify patients who are at higher risk for complications and optimize the procedure and postoperative care is contributing to the market growth. Besides this, governing agencies of numerous countries are undertaking measures to offer quality healthcare facilities that are accessible to all. This, along with significant improvements in the diagnostic technologies, is strengthening the growth of the market.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for aortic valve replacement. Some of the factors driving the North America aortic valve replacement market included extensive research and development (R&D) activities, well established healthcare facilities, integration of advanced technologies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global aortic valve replacement market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Anteris Technologies Ltd., Boston Scientific Corporation, Coroneo Inc., CryoLife Inc., Edward Lifesciences Corporation, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medtronic plc, Thubrikar Aortic Valve Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.